Navigation Links
Arpida Presents Preclinical Data on AR-2474 at ICAAC
Date:9/21/2007

REINACH and BASEL, Switzerland, September 21 /PRNewswire-FirstCall/ -- Arpida Ltd (SWX: ARPN) presented several preclinical studies on its novel topical antibiotic AR-2474 at the 47th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago. ICAAC is a major scientific conference where thousands of scientists and clinicians from all over the world gather to discuss the latest developments in the field of infectious diseases.

AR-2474 is a novel synthetic antibacterial currently under development for topical indications including treatment of infections and prevention of transmission of the "superbug" MRSA. AR-2474 is a diphenyl urea with unique properties.

F1-2100: The topical activity and potency of AR-2474 was compared with the gold standard mupirocin (Bactroban(R)) in two preclinical models of MRSA infection of the skin and of nasal decolonisation. In both models, a preliminary topical formulation of AR-2474 was demonstrated to be as efficacious as mupirocin.

F1-2094, F1-2095, F1-2096, F1-2097, F1-2100A: The in vitro microbiological activity of AR-2474 and of other compounds of the class was assessed in-house and by leading laboratories against large panels of clinical isolates. AR-2474 showed potent activity against methicillin susceptible and resistant staphylococci including nosocomial and community S. aureus isolates. Importantly, AR-2474 exhibits no cross-resistance with other classes of currently used topical treatments. The compound also exhibited potent activity against Group A and B streptococci, enterococci, pneumococci and other important pathogens responsible for causing infections of the skin, eye and mouth.

F1-2099: AR-2474 demonstrated little or no propensity for resistance development. No resistant mutants to AR-2474 could be selected using different methodologies.

F1-2098: The data showed that AR-2474 is bactericidal, exhibits a post antibiotic effect and shows no antagonism wi
'/>"/>

SOURCE Arpida Ltd.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. NimbleGen presents new tech for comparing microbe DNA
2. Wisconsin Technology Network presents symposium on saving lives by the use of Information Technology
3. Thieme Presents Unique Technology Angle at Gov.s Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...RG, Md., Nov. 5 GenVec, ...l results for the third quarter ended September 30... ($0.04 per share) for the three months ended Sept...ion ($0.08 per share) in the comparable quarter of...9, GenVec,s net loss was $14.1 million ($0.15 per ...
(Date:11/5/2009)... Nov. 5 Imagenetix, Inc....William Spencer, President and CEO of Imagenetix, ...annual LD MICRO Conference on Thursday, December 3...les. ,, About LD MICRO ,, LD MICRO is a by-i...ding undervalued companies in the micro-cap space....
(Date:11/5/2009)...., Nov. 5 Transgenomic, ...nancial results for the quarter ended September 30...ted in the tables that follow. ,, Third Quarte...366,000 or $0.01 per share for the third quarter o....01 per share for the third quarter of 2008. ,...
(Date:11/5/2009)..., Texas, Nov. 5 Wound Ma...ay that it has entered into a Letter of Intent to ...Health Technologies, Inc. (OTC Bulletin Board: VHG...00 in cash and debt, 4,000,000 shares of WNDM and ... on the Veriscrip technology being acquired from V...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...take some of the blame for a number of societys il...ty. Through the morass of Grand Theft Auto and Max...ing game has emerged, an Oregon Trail for the 21st...Illinois, has developed Frontrunner, a computer ga... November of an election year. The game follows a ...
...nty has begun using a network infrastructure devel... to its workers over the Internet from a central o...ys IT staff will be able to provide 1,600 governme...ess to government and community management applica..., according to a press release. The technology has...
...s, Minn The two- and three-port Gigabit Ethernet ...de only for the Apple G5 platform have arrived for...ed company announced Monday. , ,"There are many mu...puter center these days," said Corky Seeber, Small...dware solution that can support Apple Mac OS, Wind...
Other Biology Technology:Political video game simulates 2004 election 2Political video game simulates 2004 election 3Dane County improves law enforcement and community services 2Small-Tree extends G5 networking platform to G4, Windows and Linux 2
(Date:11/4/2009)...RLSBAD, Calif., Oct. 23 GenVault C...ample management for genomic discovery, medicine a...is, Ph.D., GenVault,s President and CEO, will be p... place on October 26th and 27th in La Jolla, CA. ,...ide an overview of the company together with recen...
(Date:11/4/2009)... CHAPEL HILL Scientists at the University of Nort...he University of California, San Francisco have de...redict new target diseases for existing drugs. , ...that compares how similar the structures of all kn...artners -- known as ligands -- of disease targets ...
(Date:11/3/2009)...ON, WI, NOVEMBER 4, 2009 -- The world,s greatest ...grape variety, human input, and something called t...rd site, soil, and climate. , Experts will dis... symposium on Wednesday, Nov. 4 in Pittsburgh. "T...esented in two parts at the 2009 Annual Meetings o...
Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Study points to new uses, unexpected side effects of already existing drugs 2Great wines come from great soils 2Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 1Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 2Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 3Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 4Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 5Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 6Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 7Amgen Announces Top Line Results of Trial to Reduce Cardiovascular Events With Aranesp 28R 29 Therapy 28TREAT 29 in CKD Patients With Type 2 Diabetes 4898 8HPV Vaccine Could Prevent Many Penile Cancers 55330 1HPV Vaccine Could Prevent Many Penile Cancers 55330 2Frank Sadeghi Joins CBCA Administrators Inc as Executive Vice President of Business Development 55326 1Frank Sadeghi Joins CBCA Administrators Inc as Executive Vice President of Business Development 55326 2
...rn mid- and upper-latitude regions are playing a s...iously thought, according to a study appearing in ... the so-called missing carbon sink, concludes that...dly high proportion of carbon dioxide from the atm...air through industrial emissions and deforestation...
...nce a comprehensive program against smoking was la... in the national Centers for Disease Control and P...(MMWR). The 2006 rate was nearly 20% lower than th...ewer smokers. The City’s rate for 2006 is the lowe...U.S. states (California, Washington, Idaho, Utah a...
...lking with a therapist or friend, writing in a jou... study by UCLA psychologists reveals why verbalizi...less intense. , Another study, with the same part...arch team, combines modern neuroscience with ancie...evidence for why “mindfulness” — the ability to li...
Other Biology News:Scientists close in on missing carbon sink 2Scientists close in on missing carbon sink 3Smoking rate has plummeted in New York City 2Putting feelings into words produces therapeutic effects in the brain 2Putting feelings into words produces therapeutic effects in the brain 3Putting feelings into words produces therapeutic effects in the brain 4Putting feelings into words produces therapeutic effects in the brain 5
UNICO Spectrophotometer from Femto Scientific
...t is the standard water based mounting medium for ... permanent preservation of peroxidase and alkaline...o use and exhibits excellent optical characteristi...medium that permits the long-term storage of antig...
...nal antibody development to targets including prot...les, DNA, and cancer-specific surface antigens. A...leted in approximately 40 days (duration may vary ...ase I: Immunization, test bleed and fusion; $2,500...
GeneAmp High Fidelity PCR from Applied Biosystems
Biology Products: